title: Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV).
abstract: Varicella zoster virus (VZV) is a ubiquitous neurotropic human herpesvirus. Primary infection usually causes varicella (chicken pox), after which virus becomes latent in ganglia along the entire neuraxis. Decades later, virus reactivates to produce herpes zoster (shingles), a painful dermatomally distributed vesicular eruption. Zoster may be further complicated by postherpetic neuralgia, VZV vasculopathy, myelitis, and segmental motor weakness. VZV reactivation has also been associated with giant cell arteritis. This overview discusses treatment of various conditions that often require both corticosteroids and antiviral drugs. Treatment for VZV-associated disease is often based on case reports and small studies rather than large-scale clinical trials. Issues that require resolution include the optimal duration of such combined therapy, more effective treatment for postherpetic neuralgia, whether some treatments should be given orally or intravenously, the widening spectrum of zoster sine herpete, and the role of antiviral therapy in giant cell arteritis.
authors.affiliation: Glasgow University Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK. Peter.Kennedy@glasgow.ac.uk.
authors.forename: Peter G E
authors.initials: PG
authors.lastname: Kennedy
mesh_terms: D002539:Cerebral Arterial Diseases / Q000821:virology; D013700:Giant Cell Arteritis / Q000821:virology; D006562:Herpes Zoster / Q000150:complications* / Q000188:drug therapy*; D014645:Herpesvirus 3, Human / Q000502:physiology*; D006801:Humans; D009187:Myelitis / Q000821:virology; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000821:virology*; D051474:Neuralgia, Postherpetic / Q000821:virology; D016896:Treatment Outcome
keywords: Antiviral agents; Corticosteroids; Postherpetic neuralgia; Varicella zoster virus; Vasculitis